ERSONTIF Trademark

Trademark Overview


On Thursday, June 16, 2016, a trademark application was filed for ERSONTIF with the United States Patent and Trademark Office. The USPTO has given the ERSONTIF trademark a serial number of 87073994. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 27, 2020. This trademark is owned by Glaxo Group Limited. The ERSONTIF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
ersontif

General Information


Serial Number87073994
Word MarkERSONTIF
Filing DateThursday, June 16, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Translation of Words in MarkThe wording "ERSONTIF" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, January 27, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 27, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 18, 2019EXTENSION 5 GRANTED
Friday, June 14, 2019EXTENSION 5 FILED
Tuesday, June 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 14, 2019TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2018EXTENSION 4 GRANTED
Monday, December 10, 2018EXTENSION 4 FILED
Monday, December 10, 2018TEAS EXTENSION RECEIVED
Friday, June 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 13, 2018EXTENSION 3 GRANTED
Wednesday, June 13, 2018EXTENSION 3 FILED
Wednesday, June 13, 2018TEAS EXTENSION RECEIVED
Friday, November 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 8, 2017EXTENSION 2 GRANTED
Wednesday, November 8, 2017EXTENSION 2 FILED
Wednesday, November 8, 2017TEAS EXTENSION RECEIVED
Saturday, June 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 15, 2017EXTENSION 1 GRANTED
Thursday, June 15, 2017EXTENSION 1 FILED
Thursday, June 15, 2017TEAS EXTENSION RECEIVED
Tuesday, December 27, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 12, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 19, 2016ASSIGNED TO EXAMINER
Wednesday, June 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 20, 2016NEW APPLICATION ENTERED IN TRAM